Literature DB >> 26277789

RETRACTED ARTICLE: Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.

Seyad Alireza Bassampour1, Reza Abdi2, Reza Bahador2, Mohammadreza Shakeri2, Ali Torkaman3, Emad Yahaghi4, Afshin Taheriazam5.   

Abstract

Entities:  

Year:  2015        PMID： 26277789     DOI： 10.1007/s13277-015-3918-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  9 in total

1.  Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.

Authors:  Fenyong Chen; Jiadong Mo; Li Zhang
Journal:  Tumour Biol       Date:  2016-07-27

2.  Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.

Authors:  Alireza Mirghasemi; Afshin Taheriazam; Seyyed Hasan Karbasy; Ali Torkaman; Mohammadreza Shakeri; Emad Yahaghi; Aram Mokarizadeh
Journal:  Cancer Cell Int       Date:  2016-11-04       Impact factor: 5.722

3.  MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.

Authors:  Zili Wang; Chenhuang Zheng; Kunqi Jiang; Jinshen He; Xu Cao; Song Wu
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

4.  MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.

Authors:  Qing Wu; Wei Zhou; Qiong Feng; Xing Liu; Yanfei Xiong; Hui Li
Journal:  Exp Ther Med       Date:  2017-10-23       Impact factor: 2.447

Review 5.  miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.

Authors:  Daojiang Li; Lu Xia; Miao Chen; Changwei Lin; Hao Wu; Yi Zhang; Songqing Pan; Xiaorong Li
Journal:  Oncotarget       Date:  2017-07-25

6.  MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy.

Authors:  Yichen Meng; Rui Gao; Jun Ma; Jianquan Zhao; Enjie Xu; Ce Wang; Xuhui Zhou
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

7.  PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.

Authors:  Daniela D'Arcangelo; Francesco Facchiano; Giovanni Nassa; Andrea Stancato; Annalisa Antonini; Stefania Rossi; Cinzia Senatore; Martina Cordella; Claudio Tabolacci; Annamaria Salvati; Roberta Tarallo; Alessandro Weisz; Angelo M Facchiano; Antonio Facchiano
Journal:  Oncotarget       Date:  2016-11-22

8.  MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2.

Authors:  Qiong Feng; Qing Wu; Xing Liu; Yanfei Xiong; Hui Li
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

9.  MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.

Authors:  Yao Xiao; Qinggang Tian; Jiantai He; Ming Huang; Chao Yang; Liansheng Gong
Journal:  Onco Targets Ther       Date:  2016-06-15       Impact factor: 4.147
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.